Actionable insights straight to your inbox

Equities logo

Regeneron Gets FDA Emergency Use Authorization for COVID-19 Antibody Therapy

The two-antibody cocktail is among the host of treatments that Trump received when he was sick in October.
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.